Mable
Latest round
- Seed
Last raised
- Jul 2022
Total raised
- $3.2M
Investors
- 5
About Mable
, trading under the name Mable, operates as a health tech company that provides genomics-based telehealth services for migraine care. In July 2022, Neurolytic Healthcare, Inc. The firm operates a platform that collects a combination of genetic and biomarker data to extract insights to offer enhanced diagnostics and provide personalized treatment for various neurological conditions. The platform offers online medical consultation services that include DNA testing services and offers precision and preventive treatment based on the DNA results for patients. The firm earns its revenue by offering its software and services at USD 279/month.
Who invested in Mable
5 investors across 1 round
See all investors in Mable
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jul 27, 2022
Amount
$3.2M
Investors
Questions about Mable
Who invested in Mable?
Mable has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mable raised?
Mable has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Mable last raise money?
Mable's most recent round on record is a Seed, in Jul 2022.
What does Mable do?
, trading under the name Mable, operates as a health tech company that provides genomics-based telehealth services for migraine care.
Where is Mable headquartered?
Mable is headquartered in San Francisco, US.
Which VCs invest in companies like Mable?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Mable's stage. Their profiles are linked below.
VCs backing healthcare it startups at Seed
Raising like Mable? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.